Anti-CD133 Antibody Market
Anti-CD133 Antibody Market Scope: Industry
Analysis, Market Size, Growth, Trends Till 2031
Request Sample Report
Anti-CD133 Antibody Market Size and Growth
The Anti-CD133 antibody market is experiencing significant growth, driven by rising demand in cancer research and therapeutic applications. The market is projected to reach approximately $XX million by 2025, with a CAGR of XX%. Increasing investment in biotechnology and personalized medicine further supports this expanding market landscape.
Companies Covered
(Covid 19 Impact Covered)
◍ BosterBio
◍ GeneTex
◍ ProSci
◍ Bioss
◍ Absolute Antibody
◍ MyBioSource
◍ Biorbyt
◍ Thermo Fisher Scientific
◍ R&D Systems
◍ Novus Biologicals
◍ BioLegend
◍ G Biosciences
◍ Cell Signaling Technology
◍ RayBiotech
◍ HUABIO
◍ Abeomics
◍ Proteintech Group
The Anti-CD133 antibody market features companies like Thermo Fisher Scientific and BioLegend, providing diverse products for cancer research. They enhance market growth through innovation, collaborations, and extensive product portfolios. Sales revenues of selected companies include Thermo Fisher: $37 billion, R&D Systems: $300 million, and GeneTex: $100 million.
◍ Miltenyi Biotec
Request Sample Report
Market Segmentation
By Application
Biotechnology
Medical
University
Others
By Product
◍ Monoclonal Antibody
Polyclonal Antibody
Request Sample Report
Market Growth
Request Sample Report
$ X Billion USD
